Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesThe New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2307563 ;PMID: 37952131Full text available |
|
2 |
Material Type: Article
|
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical LevelsJournal of the American College of Cardiology, 2017-04, Vol.69 (15), p.1952-1967 [Peer Reviewed Journal]Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 18, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.01.064 ;PMID: 28408026Full text available |
|
3 |
Material Type: Article
|
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and CancerThe New England journal of medicine, 2019-01, Vol.380 (1), p.23-32 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1811403 ;PMID: 30415637Full text available |
|
4 |
Material Type: Article
|
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesThe New England journal of medicine, 2017-08, Vol.377 (7), p.644-657 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611925 ;PMID: 28605608Full text available |
|
5 |
Material Type: Article
|
Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation StatementJAMA : the journal of the American Medical Association, 2022-04, Vol.327 (16), p.1577 [Peer Reviewed Journal]EISSN: 1538-3598 ;DOI: 10.1001/jama.2022.4983 ;PMID: 35471505Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy ElderlyThe New England journal of medicine, 2018-10, Vol.379 (16), p.1509-1518 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1805819 ;PMID: 30221597Full text available |
|
7 |
Material Type: Article
|
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant PatientsThe New England journal of medicine, 2023-04, Vol.388 (15), p.1353-1364 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2215024 ;PMID: 36876740Full text available |
|
8 |
Material Type: Article
|
Final Report of a Trial of Intensive versus Standard Blood-Pressure ControlThe New England journal of medicine, 2021-05, Vol.384 (20), p.1921-1930 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901281 ;PMID: 34010531Full text available |
|
9 |
Material Type: Article
|
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2019-01, Vol.380 (4), p.347-357 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812389 ;PMID: 30415602Full text available |
|
10 |
Material Type: Article
|
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesJournal of the American College of Cardiology, 2019-09, Vol.74 (10), p.e177-e232 [Peer Reviewed Journal]2019. American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.010 ;PMID: 30894318Full text available |
|
11 |
Material Type: Article
|
24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular RiskThe New England journal of medicine, 2022-01, Vol.386 (3), p.252-263 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2109794 ;PMID: 34767706Full text available |
|
12 |
Material Type: Article
|
Polypill Strategy in Secondary Cardiovascular PreventionThe New England journal of medicine, 2022-09, Vol.387 (11), p.967-977 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208275 ;PMID: 36018037Full text available |
|
13 |
Material Type: Article
|
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseThe New England journal of medicine, 2021-05, Vol.384 (21), p.1981-1990 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102137 ;PMID: 33999548Full text available |
|
14 |
Material Type: Article
|
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseThe New England journal of medicine, 2021-01, Vol.384 (3), p.216-228 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2028220 ;PMID: 33186492Full text available |
|
15 |
Material Type: Article
|
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational studyDiabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.3442017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13077 ;PMID: 28771923Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED TrialClinical chemistry (Baltimore, Md.), 2016-04, Vol.62 (4), p.582-592 [Peer Reviewed Journal]2016 American Association for Clinical Chemistry. ;COPYRIGHT 2016 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Apr 2016 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2015.251710 ;PMID: 26888892Full text available |
|
17 |
Material Type: Article
|
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES TrialJournal of the American College of Cardiology, 2019-09, Vol.74 (9), p.1167-1176 [Peer Reviewed Journal]Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.013 ;PMID: 30898609Full text available |
|
18 |
Material Type: Article
|
Trial of Intensive Blood-Pressure Control in Older Patients with HypertensionThe New England journal of medicine, 2021-09, Vol.385 (14), p.1268-1279 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2111437 ;PMID: 34491661Full text available |
|
19 |
Material Type: Article
|
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implicationsGut, 2020-09, Vol.69 (9), p.1691-1705 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-320622 ;PMID: 32321858Full text available |
|
20 |
Material Type: Article
|
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialThe Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31149-3 ;PMID: 31189511Full text available |